Berman Capital Advisors’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-27
Closed -$2K 1911
2020
Q3
$2K Buy
+27
New +$1.36K ﹤0.01% 1383

Berman Capital Advisors's IMMU Position: Q4 2020 in Review

Berman Capital Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 27 shares — an estimated $2K sold.

Berman Capital Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Berman Capital Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 27 Immunomedics Inc shares in Q4 2020, an estimated $2K.
  • Berman Capital Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Berman Capital Advisors's Immunomedics Inc position peaked at $2K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Berman Capital Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.